
Über diesen Podcast
Welcome to This Week in Medicine - Your Filtered Medical Journal SummaryLooking to stay up-to-date with the latest medical research but short on time? This Week in Medicine has you covered!Our AI generated podcast provides you with a convenient, on-the-go solution to keep you informed about the most significant developments in the medicine field. We understand that your time is valuable, so we've done the hard work for you.Each episode offers a filtered and concentrated summary of key journal…
235 Folgen · health
This Week In Medicine
Über diesen Podcast
Welcome to This Week in Medicine - Your Filtered Medical Journal SummaryLooking to stay up-to-date with the latest medical research but short on time? This Week in Medicine has you covered!Our AI generated podcast provides you with a convenient, on-the-go solution to keep you informed about the most significant developments in the medicine field. We understand that your time is valuable, so we've done the hard work for you.Each episode offers a filtered and concentrated summary of key journal…
Neue Folgen
- Circulation 8 2026 Semaglutide and the Inflammatory Pathways to Cardiovascular Health1. Sept. · 1 Min.
- JAMA August 2026 Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors26. Aug. · 2 Min.
- JAMA August 2026 Arginine Therapy for Sickle Cell Disease Acute Pain Episodes26. Aug. · 2 Min.
- JAMA August 2026 Predictive Utility of Coronary Artery Calcium Score Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations26. Aug. · 2 Min.
- NEJM 2026 Survodutide Once Weekly for the Treatment of Adults with Obesity24. Aug. · 2 Min.
- NEJM August 2026 Azithromycin for Preschoolers with Wheezing in the Emergency Department24. Aug. · 2 Min.
- NEJM August 2026 Carbocisteine or Hypertonic Saline for Acute Respiratory Failure24. Aug. · 2 Min.
- NEJM August 2026 Selpercatinib in Early-Stage RET Fusion–Positive Non–Small-Cell Lung Cancer14. Aug. · 2 Min.
- NEJM August 2026 In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia14. Aug. · 2 Min.
- NEJM August 2026 Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica14. Aug. · 2 Min.